Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 and R21 – Clinical Trial Not Allowed)
National Institute on Drug Abuse
Letter of Intent Due Date: November 18, 2018
Application Receipt Date(s): December 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Filed Under: Funding Opportunities